Adverum Biotechnologies, Inc. operates as a biotechnology company. The Company focuses on targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitrea... Read more
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.